Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
2018 · New England Journal of Medicine · 2,320 citations
https://doi.org/10.1056/nejmoa1804710
R
Robert J. Gray
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
350
Papers
26.9K
Citations
64
h-index
145
i10-index
Robert J. Gray is an academic researcher from Primary Children's Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Lung Cancer Treatments and Mutations & Colorectal Cancer Treatments and Studies. The author has an h-index of 64, co-authored 298 publications.
ORCID: 0000-0002-5724-4917Papers by this author
worksClinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
2019 · New England Journal of Medicine · 538 citations
https://doi.org/10.1056/nejmoa1904819
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q
2019 · Annals of Oncology · 140 citations
https://doi.org/10.1093/annonc/mdz291
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
2020 · JNCI Journal of the National Cancer Institute · 110 citations
https://doi.org/10.1093/jnci/djaa148
E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer
2018 · npj Breast Cancer · 87 citations
https://doi.org/10.1038/s41523-017-0053-3
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
2014 · British Journal of Cancer · 44 citations
https://doi.org/10.1038/bjc.2014.430
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat